Gene · 3767
NIH grants2,332
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 2,332
Download this page as JSON| Grant | Title | KCNJ11 papers | Newest fiscal year |
|---|---|---|---|
| R00HD108272 | Characterizing metabolic variability during pregnancy to understand pathways of in-utero overnutrition: an integrative analysis of metabolomics and lifestyle data | 1 | 2025 |
| R01AA018734 | Structural Analysis of Alcohol-dependent Activation of GIRKs | 1 | 2025 |
| R01AG061111 | Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArTâHS) | 1 | 2025 |
| R01AG067592 | DNA Methylation,Genetics, and Modifiable Risk Factors of Dementia in a Nationally Representative, Multi-Ethnic Cohort | 1 | 2025 |
| R01AG070830 | Contributions of astrocyte RelA signaling in aging-related neurodegenerative sequelae following TBI | 1 | 2025 |
| R01AG077000 | Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health | 1 | 2025 |
| R01AG080589 | APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease | 1 | 2025 |
| R01AI039115 | Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis | 1 | 2025 |
| R01AI057851 | Mechanisms of action, optimization and application of Bregs | 1 | 2025 |
| R01CA194057 | Transporters and Medulloblastoma | 1 | 2025 |
| R01CA220468 | Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response | 1 | 2025 |
| R01DA014204 | Regulation of Dopamine Transporter by Trafficking | 1 | 2025 |
| R01DA055656 | STRUCTURE AND FUNCTION OF MRG-FAMILY RECEPTORS | 1 | 2025 |
| R01DC001919 | Expression of Ion Channels in the Auditory System | 1 | 2025 |
| R01DK032083 | Multiple Autoantigens, Multiple Epitopes of Type 1 Diabetes | 1 | 2025 |
| R01DK046492 | Engineered Glucose Metabolism in Insulin Secreting Cells | 1 | 2025 |
| R01DK051610 | Structure-function analysis of the volume-regulated anion channel VRAC using novel LRRC8 chimeras | 1 | 2025 |
| R01DK069861 | Restoring Central Regulation of Glucose Production in Type 2 Diabetes | 1 | 2025 |
| R01DK074970 | Genetic and molecular architecture of sex-specific drug response in human islets | 1 | 2025 |
| R01DK084842 | Prevention of Placental Insufficiency Improves Beta-Cells Function | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3767/grants?page=9